HUP0200637A3 - Compounds, compositions, and their use for stimulating neuronal growth and elongation - Google Patents

Compounds, compositions, and their use for stimulating neuronal growth and elongation

Info

Publication number
HUP0200637A3
HUP0200637A3 HU0200637A HUP0200637A HUP0200637A3 HU P0200637 A3 HUP0200637 A3 HU P0200637A3 HU 0200637 A HU0200637 A HU 0200637A HU P0200637 A HUP0200637 A HU P0200637A HU P0200637 A3 HUP0200637 A3 HU P0200637A3
Authority
HU
Hungary
Prior art keywords
elongation
compositions
compounds
neuronal growth
stimulating neuronal
Prior art date
Application number
HU0200637A
Other languages
English (en)
Original Assignee
Agouron Pharmaceuticals Inc La
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agouron Pharmaceuticals Inc La filed Critical Agouron Pharmaceuticals Inc La
Publication of HUP0200637A2 publication Critical patent/HUP0200637A2/hu
Publication of HUP0200637A3 publication Critical patent/HUP0200637A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
HU0200637A 1998-07-17 1999-07-15 Compounds, compositions, and their use for stimulating neuronal growth and elongation HUP0200637A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9329998P 1998-07-17 1998-07-17
US13288499P 1999-05-06 1999-05-06

Publications (2)

Publication Number Publication Date
HUP0200637A2 HUP0200637A2 (en) 2002-08-28
HUP0200637A3 true HUP0200637A3 (en) 2003-05-28

Family

ID=26787372

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0200637A HUP0200637A3 (en) 1998-07-17 1999-07-15 Compounds, compositions, and their use for stimulating neuronal growth and elongation

Country Status (35)

Country Link
US (1) US6630472B1 (hu)
EP (1) EP1098897B1 (hu)
JP (1) JP2002520413A (hu)
KR (1) KR20010071920A (hu)
CN (1) CN1318067A (hu)
AP (1) AP2001002052A0 (hu)
AT (1) ATE268772T1 (hu)
AU (1) AU756912B2 (hu)
BG (1) BG105268A (hu)
BR (1) BR9912423A (hu)
CA (1) CA2337377A1 (hu)
DE (1) DE69917907T2 (hu)
DK (1) DK1098897T3 (hu)
EA (1) EA200100149A1 (hu)
EE (1) EE200100032A (hu)
ES (1) ES2226409T3 (hu)
GE (1) GEP20043368B (hu)
HR (1) HRP20010118A2 (hu)
HU (1) HUP0200637A3 (hu)
ID (1) ID27428A (hu)
IL (1) IL140676A0 (hu)
IS (1) IS5805A (hu)
LT (1) LT4850B (hu)
LV (1) LV12665B (hu)
NO (1) NO20010191L (hu)
NZ (1) NZ509211A (hu)
OA (1) OA11581A (hu)
PL (1) PL345598A1 (hu)
PT (1) PT1098897E (hu)
SI (1) SI20638A (hu)
SK (1) SK462001A3 (hu)
TR (1) TR200100122T2 (hu)
WO (1) WO2000004020A1 (hu)
YU (1) YU2901A (hu)
ZA (1) ZA200100320B (hu)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6818643B1 (en) * 1999-12-08 2004-11-16 Bristol-Myers Squibb Company Neurotrophic bicyclic diamides
WO2002089806A1 (en) * 2001-05-10 2002-11-14 Agouron Pharmaceuticals, Inc. Heterobicycles fkbp-ligands
EP2899192A1 (en) * 2014-01-24 2015-07-29 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders
US9914732B2 (en) 2014-01-24 2018-03-13 Max-Planck-Gesellschaft Zur Forderung Der Wissensc Haften E.V. Diazabicyclo[4.3.1]decane derivatives for treatment of psychiatric disorders

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4894366A (en) 1984-12-03 1990-01-16 Fujisawa Pharmaceutical Company, Ltd. Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
US5196352A (en) 1989-01-19 1993-03-23 Merck & Co., Inc. New FK-506 cytosolic binding protein
US5109112A (en) 1989-01-19 1992-04-28 Merck & Co., Inc. FK-506 cytosolic binding protein
US5192773A (en) 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
US5256656A (en) * 1990-07-31 1993-10-26 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives
US5187166A (en) * 1990-07-31 1993-02-16 Nisshin Flour Milling Co., Ltd. Azabicyclo derivatives and their use as antiemetics
CA2068062A1 (en) 1991-05-07 1992-11-08 Stephen A. Parent Yeast mutants
US5362629A (en) 1991-08-05 1994-11-08 President And Fellows Of Harvard College Detection of immunosuppressants
US5344831A (en) * 1992-01-31 1994-09-06 Nisshin Flour Milling Co., Ltd. Diazabicyclo derivatives
DE4219973A1 (de) 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
US5318895A (en) 1992-10-05 1994-06-07 Merck & Co., Inc. Aspergillus niger mutants
US5798355A (en) 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
JP3235913B2 (ja) * 1993-07-30 2001-12-04 エーザイ株式会社 アミノ安息香酸誘導体
US5612350A (en) 1993-11-30 1997-03-18 Abbott Laboratories Macrocyclic immunomodulators with novel cyclohexyl ring replacements
DE4341402A1 (de) 1993-12-04 1995-06-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
US5457182A (en) 1994-02-15 1995-10-10 Merck & Co., Inc. FK-506 cytosolic binding protein, FKBP12.6
US5622866A (en) 1994-06-23 1997-04-22 Merck & Co., Inc. Expression cassettes useful in construction of integrative and replicative expression vectors for Streptomyces
US5859031A (en) 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5696135A (en) 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5614547A (en) 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
US6037370A (en) 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5801197A (en) * 1995-10-31 1998-09-01 Gpi Nil Holdings, Inc. Rotamase enzyme activity inhibitors
US5786378A (en) * 1996-09-25 1998-07-28 Gpi Nil Holdings, Inc. Heterocyclic thioesters
US5801187A (en) 1996-09-25 1998-09-01 Gpi-Nil Holdings, Inc. Heterocyclic esters and amides
US5840736A (en) 1996-11-13 1998-11-24 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5811434A (en) 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
US5780484A (en) 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
AR010744A1 (es) 1996-12-09 2000-07-12 Guildford Pharmaceuticals Inc Inhibidores polipropilos de ciclofilina
US5935989A (en) 1996-12-31 1999-08-10 Gpi Nil Holdings Inc. N-linked ureas and carbamates of heterocyclic thioesters
US5874449A (en) 1996-12-31 1999-02-23 Gpi Nil Holdings, Inc. N-linked sulfonamides of heterocyclic thioesters
US5721256A (en) 1997-02-12 1998-02-24 Gpi Nil Holdings, Inc. Method of using neurotrophic sulfonamide compounds
ZA98825B (en) 1997-02-27 1998-10-19 Guilford Pharm Inc Method of using neurotrophic carbamates and ureas
US5846979A (en) 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones

Also Published As

Publication number Publication date
AU756912B2 (en) 2003-01-23
EA200100149A1 (ru) 2001-08-27
LV12665A (en) 2001-05-20
NO20010191D0 (no) 2001-01-12
TR200100122T2 (tr) 2001-08-21
LV12665B (lv) 2001-11-20
DE69917907D1 (de) 2004-07-15
YU2901A (sh) 2004-05-12
NO20010191L (no) 2001-03-16
AU4996399A (en) 2000-02-07
DK1098897T3 (da) 2004-10-18
EP1098897B1 (en) 2004-06-09
US6630472B1 (en) 2003-10-07
IS5805A (is) 2001-01-12
PL345598A1 (en) 2001-12-17
ZA200100320B (en) 2002-07-11
SK462001A3 (en) 2002-02-05
GEP20043368B (en) 2004-04-13
DE69917907T2 (de) 2005-06-30
LT4850B (lt) 2001-10-25
CA2337377A1 (en) 2000-01-27
OA11581A (en) 2004-07-23
HUP0200637A2 (en) 2002-08-28
KR20010071920A (ko) 2001-07-31
ID27428A (id) 2001-04-05
PT1098897E (pt) 2004-10-29
JP2002520413A (ja) 2002-07-09
BG105268A (en) 2001-11-30
AP2001002052A0 (en) 2001-03-31
ES2226409T3 (es) 2005-03-16
SI20638A (sl) 2002-02-28
EE200100032A (et) 2002-06-17
HRP20010118A2 (en) 2002-02-28
BR9912423A (pt) 2001-06-05
LT2001012A (en) 2001-07-25
EP1098897A1 (en) 2001-05-16
IL140676A0 (en) 2002-02-10
NZ509211A (en) 2002-10-25
CN1318067A (zh) 2001-10-17
ATE268772T1 (de) 2004-06-15
WO2000004020A1 (en) 2000-01-27

Similar Documents

Publication Publication Date Title
HK1048987A1 (zh) 化合物，合成劑及剌激神經元生長及延長的方法
ZA9710256B (en) Methods and compositions for stimulating neurite growth.
ZA9710248B (en) Methods and compositions for stimulating neurite growth.
ZA9710258B (en) Methods and compositions for stimulating neurite growth.
PL345165A1 (en) Hair treatment compositions
HUP0101685A3 (en) Hair treatment composition
MX221888B (es) Composicion plaguicida para tratamiento de semillas.
GB9813640D0 (en) Antimicrobial hair treatment composition
HUP0200275A3 (en) Seed treatment composition and preparation thereof
GB9800942D0 (en) Well treatment
EP1051169A4 (en) COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PNEUMOVIRAL INFECTIONS AND RELATED DISEASES
HUP0003478A3 (en) Synergistic fungicidal compositions, their use and process for their preparation
HUP0200637A3 (en) Compounds, compositions, and their use for stimulating neuronal growth and elongation
GB2354944B (en) Skin treatment compositions
GB9917346D0 (en) Medicament for treating premature ejaculation
PL345806A1 (en) Hair treatment compositions
GB9800954D0 (en) Well treatment with micro-organisms
HU9503428D0 (en) Fungicidal compositions for seed treatment
GB9810856D0 (en) Hair treatment composition
GB9815497D0 (en) Treatment
GB9818524D0 (en) Inorgasmia treatment
GB9828550D0 (en) Treatment
GB9905907D0 (en) Sterilant composition
GB9605651D0 (en) Sterilant composition
HUP9902857A3 (en) Composition for stimulating tissue growth